Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Open-label Follow-up of Brivaracetam Adjunctive Therapy in Epilepsy
jRCT2080222434Phase 3Completed
- Sponsor
- UCB
- Start
- Mar 2014
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of brivaracetam in epilepsy, sponsored by UCB. Started Mar 2014; status: completed.
02
Drugs
brivaracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on jRCT2080222434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222434.